Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Sensyne Health in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $1.55.
Current Consensus is
The current consensus among 1 contributing investment analysts is to buy stock in Sensyne Health.
Sensyne Health Plc is a healthcare technology company, which engages in the discovery and development of new medicines. It also develop clinically validated software applications by artificial intelligence comprises prescribed digital therapeutics and hospital systems. Its products include SEND, GDm-Health, CVm-Health, DBm-Health, CleanSpace, and EDGE. The company was founded on June 20, 2018 and is headquartered in Oxford, the United Kingdom.